BridgeBio Pharma Inc
NASDAQ:BBIO

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
NASDAQ:BBIO
Watchlist
Price: 24.11 USD -2.74% Market Closed
Market Cap: 4.5B USD
Have any thoughts about
BridgeBio Pharma Inc?
Write Note

BridgeBio Pharma Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BridgeBio Pharma Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
BridgeBio Pharma Inc
NASDAQ:BBIO
Total Equity
-$1.2B
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$6B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.4B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Equity
$7.5B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$15.6B
CAGR 3-Years
18%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$29.3B
CAGR 3-Years
19%
CAGR 5-Years
23%
CAGR 10-Years
28%

See Also

What is BridgeBio Pharma Inc's Total Equity?
Total Equity
-1.2B USD

Based on the financial report for Sep 30, 2024, BridgeBio Pharma Inc's Total Equity amounts to -1.2B USD.

What is BridgeBio Pharma Inc's Total Equity growth rate?
Total Equity CAGR 3Y
-18%

Over the last year, the Total Equity growth was -2%. The average annual Total Equity growth rates for BridgeBio Pharma Inc have been -18% over the past three years .

Back to Top